In vitro evolution of single-chain antibodies using mRNA display

Isao Fukuda, Kanehisa Kojoh, Noriko Tabata, Nobuhide Doi, Hideaki Takashima, Etsuko Miyamoto-Sato, Hiroshi Yanagawa

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Here we describe the application of the in vitro virus mRNA display method, which involves covalent linkage of an in vitro-synthesized antibody (phenotype) to its encoding mRNA (genotype) through puromycin, for in vitro evolution of single-chain Fv (scFv) antibody fragments. To establish the validity of this approach to directed antibody evolution, we used random mutagenesis by error-prone DNA shuffling and off-rate selection to improve the affinity of an anti-fluorescein scFv as a model system. After four rounds of selection of the library of mRNA-displayed scFv mutants, we obtained six different sequences encoding affinity-matured mutants with five consensus mutations. Kinetic analysis of the mutant scFvs revealed that the off-rates have been decreased by more than one order of magnitude and the dissociation constants were improved ∼30-fold. The antigen-specificity was not improved by affinity maturation, but remained similar to that of the wild type. Although the five consensus mutations of the high-affinity mutants were scattered over the scFv sequence, analysis by site-directed mutagenesis demonstrated that the critical mutations for improving affinity were the two that lay within the complementarity determining regions (CDRs). Thus, mRNA display is expected to be useful for rapid artificial evolution of high-affinity diagnostic and therapeutic antibodies by optimizing their CDRs.

Original languageEnglish
Article numbere127
JournalNucleic Acids Research
Volume34
Issue number19
DOIs
Publication statusPublished - 2006 Nov

Fingerprint

Single-Chain Antibodies
Complementarity Determining Regions
Messenger RNA
Mutation
Antibodies
DNA Shuffling
Puromycin
Site-Directed Mutagenesis
Fluorescein
Mutagenesis
Sequence Analysis
Genotype
Viruses
Phenotype
Antigens
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Genetics

Cite this

Fukuda, I., Kojoh, K., Tabata, N., Doi, N., Takashima, H., Miyamoto-Sato, E., & Yanagawa, H. (2006). In vitro evolution of single-chain antibodies using mRNA display. Nucleic Acids Research, 34(19), [e127]. https://doi.org/10.1093/nar/gkl618

In vitro evolution of single-chain antibodies using mRNA display. / Fukuda, Isao; Kojoh, Kanehisa; Tabata, Noriko; Doi, Nobuhide; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi.

In: Nucleic Acids Research, Vol. 34, No. 19, e127, 11.2006.

Research output: Contribution to journalArticle

Fukuda, I, Kojoh, K, Tabata, N, Doi, N, Takashima, H, Miyamoto-Sato, E & Yanagawa, H 2006, 'In vitro evolution of single-chain antibodies using mRNA display', Nucleic Acids Research, vol. 34, no. 19, e127. https://doi.org/10.1093/nar/gkl618
Fukuda I, Kojoh K, Tabata N, Doi N, Takashima H, Miyamoto-Sato E et al. In vitro evolution of single-chain antibodies using mRNA display. Nucleic Acids Research. 2006 Nov;34(19). e127. https://doi.org/10.1093/nar/gkl618
Fukuda, Isao ; Kojoh, Kanehisa ; Tabata, Noriko ; Doi, Nobuhide ; Takashima, Hideaki ; Miyamoto-Sato, Etsuko ; Yanagawa, Hiroshi. / In vitro evolution of single-chain antibodies using mRNA display. In: Nucleic Acids Research. 2006 ; Vol. 34, No. 19.
@article{0d358a77fc514b4fa531242406bae127,
title = "In vitro evolution of single-chain antibodies using mRNA display",
abstract = "Here we describe the application of the in vitro virus mRNA display method, which involves covalent linkage of an in vitro-synthesized antibody (phenotype) to its encoding mRNA (genotype) through puromycin, for in vitro evolution of single-chain Fv (scFv) antibody fragments. To establish the validity of this approach to directed antibody evolution, we used random mutagenesis by error-prone DNA shuffling and off-rate selection to improve the affinity of an anti-fluorescein scFv as a model system. After four rounds of selection of the library of mRNA-displayed scFv mutants, we obtained six different sequences encoding affinity-matured mutants with five consensus mutations. Kinetic analysis of the mutant scFvs revealed that the off-rates have been decreased by more than one order of magnitude and the dissociation constants were improved ∼30-fold. The antigen-specificity was not improved by affinity maturation, but remained similar to that of the wild type. Although the five consensus mutations of the high-affinity mutants were scattered over the scFv sequence, analysis by site-directed mutagenesis demonstrated that the critical mutations for improving affinity were the two that lay within the complementarity determining regions (CDRs). Thus, mRNA display is expected to be useful for rapid artificial evolution of high-affinity diagnostic and therapeutic antibodies by optimizing their CDRs.",
author = "Isao Fukuda and Kanehisa Kojoh and Noriko Tabata and Nobuhide Doi and Hideaki Takashima and Etsuko Miyamoto-Sato and Hiroshi Yanagawa",
year = "2006",
month = "11",
doi = "10.1093/nar/gkl618",
language = "English",
volume = "34",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - In vitro evolution of single-chain antibodies using mRNA display

AU - Fukuda, Isao

AU - Kojoh, Kanehisa

AU - Tabata, Noriko

AU - Doi, Nobuhide

AU - Takashima, Hideaki

AU - Miyamoto-Sato, Etsuko

AU - Yanagawa, Hiroshi

PY - 2006/11

Y1 - 2006/11

N2 - Here we describe the application of the in vitro virus mRNA display method, which involves covalent linkage of an in vitro-synthesized antibody (phenotype) to its encoding mRNA (genotype) through puromycin, for in vitro evolution of single-chain Fv (scFv) antibody fragments. To establish the validity of this approach to directed antibody evolution, we used random mutagenesis by error-prone DNA shuffling and off-rate selection to improve the affinity of an anti-fluorescein scFv as a model system. After four rounds of selection of the library of mRNA-displayed scFv mutants, we obtained six different sequences encoding affinity-matured mutants with five consensus mutations. Kinetic analysis of the mutant scFvs revealed that the off-rates have been decreased by more than one order of magnitude and the dissociation constants were improved ∼30-fold. The antigen-specificity was not improved by affinity maturation, but remained similar to that of the wild type. Although the five consensus mutations of the high-affinity mutants were scattered over the scFv sequence, analysis by site-directed mutagenesis demonstrated that the critical mutations for improving affinity were the two that lay within the complementarity determining regions (CDRs). Thus, mRNA display is expected to be useful for rapid artificial evolution of high-affinity diagnostic and therapeutic antibodies by optimizing their CDRs.

AB - Here we describe the application of the in vitro virus mRNA display method, which involves covalent linkage of an in vitro-synthesized antibody (phenotype) to its encoding mRNA (genotype) through puromycin, for in vitro evolution of single-chain Fv (scFv) antibody fragments. To establish the validity of this approach to directed antibody evolution, we used random mutagenesis by error-prone DNA shuffling and off-rate selection to improve the affinity of an anti-fluorescein scFv as a model system. After four rounds of selection of the library of mRNA-displayed scFv mutants, we obtained six different sequences encoding affinity-matured mutants with five consensus mutations. Kinetic analysis of the mutant scFvs revealed that the off-rates have been decreased by more than one order of magnitude and the dissociation constants were improved ∼30-fold. The antigen-specificity was not improved by affinity maturation, but remained similar to that of the wild type. Although the five consensus mutations of the high-affinity mutants were scattered over the scFv sequence, analysis by site-directed mutagenesis demonstrated that the critical mutations for improving affinity were the two that lay within the complementarity determining regions (CDRs). Thus, mRNA display is expected to be useful for rapid artificial evolution of high-affinity diagnostic and therapeutic antibodies by optimizing their CDRs.

UR - http://www.scopus.com/inward/record.url?scp=33750982135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750982135&partnerID=8YFLogxK

U2 - 10.1093/nar/gkl618

DO - 10.1093/nar/gkl618

M3 - Article

VL - 34

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 19

M1 - e127

ER -